Іздеу

Шығарылым
Атауы
Авторлар
The spectrum of adverse events in the treatment of multidrug-resistant tuberculosis among people receiving antiretroviral therapy
Degtyareva S., Zimina V., Pokrovskaya A., Konovalova A., Volchenkov G.
Experience with enfuvirtide (fuzeon) in the treatment regimens for HIV infection
Beketova E., Bykov S.
Two-drug antiretroviral therapy regimen with dolutegravir and lamivudine for previously untreated HIV-infected patients
Koshkin A., Pokrovskaya A.
Phosphaside and lamivudine as a nucleoside base of first-line antiretroviral therapy regimens for HIV infection
Ivanova E.
EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY REGIMENS CONTAINING ETRAVIRINE FOR HIV-INFECTED PATIENTS
KRAVCHENKO A., KANESTRI V., GANKINA N.
Lipodystrophy syndrome in patients with HIV infection
Khasanova G.
THE NOVEL HIV NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR RILPIVIRINE: A REVIEW OF INTERNATIONAL CLINICAL TRIALS
KANESTRI V.
Impact of antiretroviral therapy on the development of the HIV-infection epidemic in the Russian Federation
Sokolova E., Ladnaia N., Pokrovsky V., Kravchenko A., Kozyrina N., Yurin O., Chekryzhova D.
THE PROBLEM OF BODY WEIGHT GAIN IN HIV-INFECTED PATIENTS DURING ANTIRETROVIRAL THERAPY
KRAVCHENKO A., KANESTRI V.
Results of examination of pregnant women’s sexual partners for HIV infection: The experience of the Sverdlovsk Region
Podymova A.
A fixed-dose combination of abacavir/lamivudine as a nucleoside basis for first-line antiretroviral therapy regimens
Konnov V., Kozyreva N., Kanestri V., Narsia R., Yurin O.
COST-MINIMIZATION ANALYSIS OF ETRAVIRINE AND RALTEGRAVIR USED IN THERAPY FOR HIV INFECTION
BELOUSOV Y., AFANASYEVA E., BELOUSOV D., BEKETOV A.
Human immunodeficiency virus and death
Pokrovsky V.
Influenza in the HIV infected
Provorova V., Krasnova E., Khokhlova N., Kuimova I., Izvekova I.
Use of non-boosted atazanavir in clinical practice
Kanestri V., Yagodkin M.
Hepatotoxicity of antiretroviral therapy in HIV-infected patients
Kanestri V., Kravchenko A., Gankina N.
CONTRIBUTION OF A FIXED-DOSE ABACAVIR/LAMIVUDINE COMBINATION TO IMPROVING TREATMENT COMPLIANCE IN HIV-INFECTED PATIENTS
KANESTRI V.
The place of antiretroviral therapy in the behavioral strategies aimed at maintaining the health and quality of counseling of people living with HIV
Kozyrina N., Belyaeva V., Ekaterina S., Semikova S., Lebedeva E., Gavrilova O., Galiullin N., Beshimov A., Khoraskina E., Narkevich A., Suvorova Z., Khokhlova O.
ATAZANAVIR IN BASIC ANTIRETROVIRAL THERAPY REGIMENS: A REVIEW OF CONVINCING DATA
MAKSIMOV S.
The first results of using the combined drug rilpivirine/tenofovir/ emtricitabine in Russian patients with HIV infection in real clinical practice
Sizova N., Volova L., Malyuzhenko I., Isaeva G., Koveleno A., Minaeva S., Topolskaya S., Voronin E., Okhonskaya L.
PROSPECTS FOR THE LONG-TERM EFFICACY OF FOSAMPRENAVIR (TELZIR) USED AS PART OF ANTIRETROVIRAL THERAPY IN HIV-INFECTED PATIENTS
GUSHCHINA Y., KUVAEVA M.
USE OF A FIXED-DOSE ANTIRETROVIRAL DRUG IN HIV-INFECTED PREGNANT WOMEN
Samarina A., Mozaleva O., Martirosian M., Skryabneva T.
THE HIV NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ABACAVIR AND LAMIVUDINE IN FIRST-LINE ANTIRETROVIRAL THERAPY REGIMENS
KRAVCHENKO A., KANESTRI V.
HIV drug resistance: Dolutegravir is a second-generation HIV integrase inhibitor
Kravchenko A., Kanestri V.
DUAL ANTIRETROVIRAL THERAPY WITH LOPINAVIR AND RITONAVIR
Yurin O., KRAVCHENKO A., KANESTRI V., POKROVSKAYA A., SHAKHGILDYAN V., VOLKOVA S.
CLINICOECONOMIC ANALYSIS OF THE USE OF MARAVIROC VERSUS OTHER RESERVE DRUGS IN PATIENTS WHO HAVE EXPERIENCED ANTIRETROVIRAL THERAPY FOR HIV INFECTION
PYADUSHKINA E., GORYAYNOV S., OMELYANOVSKY V., AVXENTYEVA M., REBROVA O.
Studying the transmission of HIV-1 drug resistance in the Republic of Armenia using bioinformatics methods
Osadchaya O., Eroshkin P., Kirichenko A., Lapovok I., Saleeva D., Lopatukhin A., Shlykova A., Kireev D., Grigoryan T., Petrosyan A., Sarhatyan T., Pokrovsky V.
MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME DURING ANTIRETROVIRAL THERAPY IN PATIENTS WITH HIV INFECTION
KRAVCHENKO A., ZIMINA V., VIKTOROVA I., SITDYKOVA Y.
A virologic response as a hallmark of excellence: TDF/FTC or TDF/3TC
Kozyrina N., Yurin O.
ABAKAVIR I LAMIVUDIN KAK NUKLEOZIDNAYa OSNOVA ANTIRETROVIRUSNOY TERAPII
KOZYRINA N., NARSIA R., YURIN O.
EXPERIENCE WITH THE HIV PROTEASE INHIBITOR FOSAMPRENAVIR IN RUSSIAN PRACTICE
VOLKOVA S., PODYMOVA A.
Results of post-registration study of efficacy and safety of antiretroviral therapy schemes including elsulfavirine in previously non-treated HIV-infected patients (PASS-1)
Kravchenko A., Shimonova T., Ulianova Y., Kuznetsova A., Isaeva G., Sizova N., Palaguta A., Baburina A., Shevchenko V., Ulchiekova M., Fisenko E., Radzikhovskaya M., Musatov V., Anoprienko E., Malyugina N., Pokrovskaya A., Zhuravkova O., Elistratova O., Volova L., Ushakova A., Lomakina E., Laseeva M., Terekhova M.
The use of doravirme as part of antiretroviral therapy regimens in patients with resistance mutations
Orlova-Morozova E., Pronin A.
The demographic and clinical characteristics of HIV-infected women in routine clinical practice in the Russian Federation: Results of a multicenter crosssectional non-interventional study
Voronin E., Afonina L., Orlova-Morozova E., Plotnikova Y., Radzikhovskaya M.
The efficacy and safety of a new Russian HIV non-nucleoside reverse transcriptase inhibitor (VM-1500, Elpivirine) as a component in an antiretroviral therapy regimen
Kravchenko A., Orlova-Morozova E., Shimonova T., Kozyrev O., Nagimova F., Bychko V., Vostokova N., Zozulya O.
USE OF A COMBINATION OF THE ANTIRETROVIRAL DRUGS DARUNAVIR ® AND ETRAVIRINE ® IN A PATIENT WITH A RESISTANT HIV STRAIN
MIKOVA O., MOISEEVA G.
CLINICAL AND LABORATORY FEATURES OF ABNORMALITIES IN THE CERVIX UTERI, EXTERNAL GENITALS, AND VAGINA IN HIV-INFECTED PATIENTS
SUNDUKOV A., GAFUROV Y., EVSYUKOV O.
Dynamics of HIV reservoirs during the use of a two-component regimen with dolutegravir and lamivudine in HIV-infected patients who have not previously received treatment
Pokrovskaya A., Kirichenko A., Khokhlova O., Kulabukhova E., Goliusova M., Kireev D., Yurin O.
HIV-1 drug resistance in patients with virological inefficiency on ART in Russia in 2013-2021
Kirichenko A., Kireev D., Shlykova A., Lopatukhin A., Lapovok I., Saleeva D., Kravchenko A., Pokrovsky V.
Combined antiretroviral drugs containing lamivudine and zidovudine for the treatment of HIV infection
Sizova N., Korneeva T., Bratkova V., Sotnikova A., Rassokhin V.
Antiretroviral therapy regimens containing the HIV protease inhibitor saquinavir
Kravchenko A.
Experience with the HIV protease inhibitor fosamprenavir in first-line antiretroviral therapy regimens in the Chelyabinsk Region
Moskvicheva M., Radzikhovskaya M.
USE OF THE FUSION INHIBITOR ENFUVIRTIDE IN ANTIRETROVIRAL THERAPY REGIMENS FOR HIV-INFECTED PATIENTS
Kravchenko A., Kanestri V.
Нәтижелер 43 - 1/43
Сыбырсөздер:
  • Негізгі сөздер тіркелімге сезімтал< / li>
  • Ағылшын предлогтары мен одақтары еленбейді
  • Әдепкі бойынша іздеу барлық негізгі сөздер үшін жасалады (агенс AND экспериенцер)
  • Белгілі бір терминді табу үшін OR қолданыңыз. білім беру OR оқыту
  • мысалы, күрделі сөз тіркестерін жасау үшін жақшаларды қолданыңыз. мұрағат ((журналдар OR конференциялар) NOT диссертациялар)
  • Нақты фразаны табу үшін, мысалы, тырнақшаларды қолданыңыз. "ғылыми зерттеулер"
  • сөзді - (сызықша) немесе not операторының көмегімен алып тастаңыз; мысалы. сұлулық байқауы< / em > немесе сұлулық байқауы< / em > < / li>
  • мысалы, нұсқа ретінде * қолданыңыз. ғылым* "ғылыми","ғылыми"және т. б. сөздерді қамтиды< / li> < / < / к-сі>